Abiopharma

Kraig Biocraft Laboratories, Inc. is a biotechnology company focused on the development of high performance polymers. Our genetic engineering research has succeeded in developing what many considered to be the holy grail of material science: A practical, cost-effective, and eco-responsible technology for producing recombinant spider silk based fibers on an industrial scale. We are moving rapidly to commercialize our spider silk technology, which we believe will have a significant impact on the global textiles industry. At the same time we are continuing to work to create new stronger and more flexible spider silk based fibers with potentially broad applications for consumers and industry in the multi-billion dollar marketplace for textiles and performance polymers. At Kraig, we are passionate about pioneering the research, development and commercialization of the next generation of high performance fibers based on genetic engineered spider silk.

Additional info from OTC:
Kraig Biocraft Laboratories, Inc. is a biotechnology company focused on the development of high performance polymers. Our genetic engineering research has succeeded in developing what many considered to be the holy grail of material science: A practical, cost-effective, and eco-responsible technology for producing recombinant spider silk based fibers on an industrial scale. We are moving rapidly to commercialize our spider silk technology, which we believe will have a significant impact on the global textiles industry. At the same time we are continuing to work to create new stronger and more flexible spider silk based fibers with potentially broad applications for consumers and industry in the multi-billion dollar marketplace for textiles and performance polymers. At Kraig, we are passionate about pioneering the research, development and commercialization of the next generation of high performance fibers based on genetic engineered spider silk.